OncoZenge is a Swedish biotechnology company focused on the development of treatments for pain management in patients with oral conditions. The company’s activities center on pharmaceutical product development and related clinical and regulatory work.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!